HCC in the Setting of Hepatitis B: Key Issues for Clinicians Providing Care for Liver Diseases

Download this PDF guide outlining key information on HCC risk assessment, screening, and surveillance in the setting of Hepatitis B infection.

Robert S. Brown, Jr., MD, MPH Released: February 22, 2021

Gain expert insight on practical approaches to HCC risk assessment, HCC screening and surveillance, and HCC management in the setting of patients with hepatitis B.

Robert S. Brown, Jr., MD, MPH Paul Y. Kwo, MD Norah Terrault, MD, MPH Released: March 26, 2021

Watch this dynamic panel discussion on HCC risk, screening, surveillance, and management, in the setting of patients with hepatitis B.

Robert S. Brown, Jr., MD, MPH Paul Y. Kwo, MD Norah Terrault, MD, MPH Physicians: maximum of 1.25 AMA PRA Category 1 Credits™ Pharmacists: 1.25 contact hours (0.125 CEUs) Released: March 26, 2021 Expired: March 25, 2022

Introduction: HCC in the Setting of Hepatitis B

Assessing HCC Risk in Patients With HBV

HCC Screening and Surveillance in Patients With HBV

Management of HCC: Liver Specialists as Leaders of the Multidisciplinary Team

亚太地区在评估 HBV 患者的 HCC 风险和跨学科管理方面的注意事项

Grace LH Wong, 医学博士 Released: April 16, 2021

Asia-Pacific considerations in assessing HCC risk in patients with HBV and interdisciplinary management of HCC.

Grace LH Wong, MD Released: April 15, 2021

Patients achieving a functional cure for chronic hepatitis B with nucleos(t)ide analogue treatment may still develop HCC. What tools do we have to predict which patients will experience progression of liver disease?

Yasuhito Tanaka, MD, PhD Released: May 6, 2021